Research News - January 8, 2016

Please click here to read the Partners Office for Interactions with Industry’s Annual Report for FY15.

Please click here to read the latest update from the NIH Office of Extramural Research.

Please click here to read the latest news from the Patient-Centered Outcomes Research Institute.

Wednesday, April 6, 2016, 10:15 am- 1:45 pm, Simches Building, Second Floor & Simches 3.120 (SERI)

Now is the chance to exhibit your research! ECOR is now accepting abstracts for the SAC Poster Session!

Deadline for submission: Tuesday, January 19, 2016

The annual Scientific Advisory Committee (SAC) Poster Session gives researchers the opportunity to create a compelling visual display of their work and present it to some of the best scientific minds in the nation. The poster session is an essential part of the two-day meeting, which highlights excellence in research at MGH. Twelve Posters of Distinction will be chosen to receive a $1000 travel award. A review panel will select finalists from the submitted abstracts. Awards will be restricted to junior faculty and trainees.

SPACE IS LIMITED
Poster abstract submissions will be accepted on a first come, first served basis. Authors must be MGH employees. Abstracts on any type of research are eligible for submission; however, authors may only submit ONE abstract.

NEW FOR 2016!
This year, we are going completely electronic! The SAC poster session will only feature electronic posters displayed on ePosterBoards. We encourage you to create dynamic and visually captivating presentations that highlight the fascinating aspects of your research. There will be a total of two poster sessions - each poster will only be assigned to one session. ECOR will have multiple training forums on how to create electronic posters.

PRIZES
Twelve $1,000 Poster of Distinction Awards to be used for Scientific Meeting Travel

HOW TO SUBMIT
Please click here for more information and to submit a poster abstract!

QUESTIONS
If you have problems or questions please email sac@partners.org

Again, space is limited! Submit your abstract early!

Monday, January 11, 1:00pm - 2:00pm, Simches 3.130

Presenter: BJ Kerns, VP, Global Technical Affairs

There is a current need to perform molecular testing on a variety of sample types: FFPE tissue, frozen tissue, biofluids and cell lysates.  A limitation to the utilization of this resource for molecular researchers is the difficulty of nucleic acid extraction from small and/or degraded samples. For more information on this seminar click here or read the abstract.

Tuesday, January 12, 4:00 PM, CNY 149, Room 2.204

Systemic inflammation in ischemic heart disease
Matthias Nahrendorf, MD, PhD
Associate Professor, MGH Center for Systems Biology

Monday, January 25, 4:00 – 5:00 pm, CNY 149, Isselbacher Auditorium – 7th Floor

“Unique Isomerase Pin1 in Cancer and Alzheimer’s: from Gene Cloning to Drug Discovery”
Kun Ping Lu, MD, PhD.
Professor of Medicine, Harvard Medical School
Chief, Division of Translational therapeutics
Department of Medicine and the Cancer Center
Beth Israel Deaconess Medical Center

Registration at Lobby Security Desk may be required. Shuttle bus leaves MGH Main Campus (Blossom St) every 15 minutes.

Wednesday, February 3, 12:00 - 1:00 pm, MGH Main Campus, details provided upon registration

The Center for Faculty Development's Office for Research Career Development presents a seminar for HMS faculty and trainees.

Responsibilities of Mentors and Mentees

This interactive seminar will cover the responsibilities of mentors and mentees, and the characteristics of good mentoring relationships, to help you get the most out of this critical aspect of your career development. More specifically, this seminar will discuss:

• What should you look for in a mentor?
• How do you make the transition from mentee to mentor?
• Where can you find mentors for your mid-career advancement?

Speaker: Stephanie Seminara, MD, Professor of Medicine, HMS, MGH Reproductive Endocrine Unit, Bob and Laura Reynolds MGH Research Scholar

 Please click here to register by Wed, Jan 20.

Note: This seminar counts as one of the four required lectures in part III of Partners RCR training. All are welcome, but space is limited and registration preference will be given to those with RCR training requirements.

Tuesday, February 9, 2016, 8:00 am – 4:30 pm, Simches Research Building, 3rd Floor Conference Facility

Please join us for the 6th Annual Research Administrators Retreat.  All MGH Department Administrators and Partners Central Administrators are invited to attend, as well as any interested investigators.  The retreat will be equally beneficial to those who are new to research administration and those who have been in the field for years, and will be a great opportunity to network with your colleagues.

For the first time, the retreat will feature a Networking Session to help build relationships throughout the research community. 

Please note that registration is required and is on a first come, first served basis as attendance is limited.  The deadline to register is Friday, January 29, 2016.  Please click here to register.

If you have any questions regarding the retreat, please email researchmanagement@mgh.harvard.edu .

Applications are now being accepted by the Executive Committee on Research (ECOR) for the Fund for Medical Discovery (FMD) Clinical Fellowship Awards!

What are they?
MD fellows, PhD postdoctoral research fellows and Instructors within 5 years of the start of their fellowship training at Massachusetts General Hospital are encouraged to apply.
The award may be used only for salary and fringe benefits. The awards are not transferable to any other institution and will be effective on or about July 1, 2016. The awards are unrestricted as to area of study. 

How much is each award?
The awards will include a stipend of $40,000 plus applicable fringe benefits and 15% indirect costs.

When is the deadline?
Monday, February 1, 2016 - 5:00 PM

How do I learn more and apply?
Click here to read more and apply online!

For a guide to help make your application more competitive click here. 

The purpose of the NHLBI Outstanding Investigator Award (OIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors (PDs)/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrate their ability to make major contributions to heart, lung, blood and sleep (HLBS) research.

The NHLBI OIA is intended to support a research program, rather than a research project, by providing the primary and most likely sole source of NHLBI funding on individual grant awards. The NHLBI OIA will support the research program of NHLBI-funded investigators for up to seven years. The NHLBI OIA will provide investigators increased freedom to conduct research that breaks new ground or extends previous discoveries in new directions. It will also allow PDs/PIs to take greater risks and to pursue research that requires a longer timeframe. Research supported by the NHLBI OIA should be within the scope of the NHLBI mission, sleep disorders closely-coupled to HLB outcomes, or basic sleep and circadian regulation.

Eligibility to apply through this FOA is limited to PDs/PIs who meet all of the following criteria:

• Are currently PD/PI on at least two NHLBI R01-equivalent (defined here as R01, R37, DP1, or DP2) awards;
• Have received continuous R01-equivalent support from the NHLBI for at least the past four years as a PD/PI; and
• Can commit a minimum of 50% research effort (i.e., minimum of six calendar months) throughout the duration of the NHLBI OIA.

Investigators receiving NHLBI OIAs must relinquish their other NHLBI research grants, with a limited number of exceptions as outlined in Part 2, Section I.

Although MGH may submit more than one application to this program, provided each is scientifically distinct, an institutional review and a letter of nomination is required for applicants to this funding opportunity. Anyone interested in being considered for nomination to this program must contact ECOR at ecor@mgh.harvard.edu by Friday, January 29 at 12:00 pm (noon).

The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to Program Directors /Principal Investigators (PDs/PIs) who currently have two NHLBI R01 awards, of which one must be an NHLBI-funded NIH Early Stage Investigator R01 award, and whose outstanding record of research demonstrate their ability to make major contributions to heart, lung, blood and sleep (HLBS) research.

The NHLBI EIA is intended to support a research program, rather than a research project, by providing the primary, and most likely sole, source of NHLBI funding on individual grant awards. The NHLBI EIA will support the research program of NHLBI-funded investigators for up to seven years. The NHLBI EIA will provide investigators increased freedom to conduct research that breaks new ground or extends previous discoveries in new directions. It will also allow PDs/PIs to take greater risks and to pursue research that requires a longer timeframe. Research supported by the NHLBI EIA should be within the scope of the NHLBI mission, sleep disorders closely-coupled to HLB outcomes, or basic sleep and circadian regulation.

Eligibility to apply through this FOA is limited to PDs/PIs who meet all of the following criteria:

• Currently have two NHLBI R01 awards, of which one must be an NHLBI-funded NIH Early Stage Investigator (ESI) R01; and
• Can commit a minimum of 50% research effort (i.e., minimum of six calendar months) throughout the duration of the NHLBI EIA.

Investigators receiving NHLBI EIAs must relinquish their other NHLBI research grants, with a limited number of exceptions as outlined in Part 2, Section I.    

Although MGH may submit more than one application to this program, provided each is scientifically distinct, an institutional review and a letter of nomination is required for applicants to this funding opportunity. Anyone interested in being considered for nomination to this program must contact ECOR at ecor@mgh.harvard.edu by Friday, January 29 at 12:00 pm (noon).

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these funding opportunities.  Note that proposals are still routed through the standard InfoEd/Research Management process.

• Charles A. King Trust Postdoctoral Research Fellowship Program, Health Resources in Action (HRiA)/The Medical Foundation
• Basil O'Connor Starter Scholar Research Award, March of Dimes Birth Defects Foundation

Please click here for further details on these funding opportunities.

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

• Name of the Principal Investigator with appropriate contact information
• A descriptive title of the potential application
• Brief description of the project
• Brief description of why you specifically should be selected to receive institutional nomination for this award

In the event that there is more than one MGH investigators interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.

• NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
• Intellectual and Developmental Disabilities Research Centers 2016 (U54)
• W. M. Keck Foundation Research Program Grants
• Superfund Hazardous Substance Research and Training Program (P42)
• International Centers of Excellence for Malaria Research (U19)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.

For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm

Massachusetts Eye and Ear Gliklich Innovation Scholars Program
Application Deadline: February 1, 2016

MGH ECOR Formulaic Bridge Funding Support
Application Deadline: February 7, 2016; 7th day of each month

Boston Biomedical Innovation Center (B-BIC) Accepting PILOT & DRIVE Grant Pre-Proposals

Innovation at Partners HealthCare: Fall Newsletter

Information Systems News - Fall 2015

SAVE THE DATE! SAC 2016 - April 6 & 7

Looking for something you saw in a previous Research News release? Check out our archive!